Uwe Röhrhoff new Chief Executive Officer of Gerresheimer AG

Düsseldorf (ots) -

- Querverweis: Bildmaterial ist abrufbar unter
http://www.presseportal.de/galerie.htx?type=obs -

Uwe Röhrhoff becomes the new Chief Executive Officer of
Gerresheimer AG on June 22, 2010. Uwe Röhrhoff, who has been a member
of the Management Board since 2003, was appointed to his new position
by the Supervisory Board in March. Uwe Röhrhoff (48) succeeds Dr.
Axel Herberg, who headed the business for ten years as CEO and is
changing to the Supervisory Board on September 1, 2010.

"We are delighted to have found in Uwe Röhrhoff the ideal CEO for
Gerresheimer AG," says Supervisory Board Chairman Gerhard Schulze:
"Mr. Röhrhoff stands for continuity and experience and enjoys the
trust of customers and employees equally."

Uwe Röhrhoff, a business graduate, works for Gerresheimer for 20
years and was recently responsible for the Moulded Glass Division and
the Life Science Research Division. In addition, he has played a
decisive role in the expansion of Gerresheimer's US and Chinese
business. Uwe Röhrhoff comments: "We will continue in the future to
focus on the successful business in the field of pharma and
healthcare. At the same time we want to push ahead with
internationalization. We are very well positioned and solidly
financed to achieve further profitable growth in the future."

As CEO, Uwe Röhrhoff will continue to manage the Moulded Glass
Division directly. On the Management Board, Dr. Max Raster takes over
responsibility for the Life Science Research Division in addition to
the Tubular Glass Division.

Uwe Röhrhoff joined Gerresheimer in 1991 and initially worked in
controlling. He became CEO of the US subsidiary Gerresheimer Glass
Inc. in 2001 and has many years' experience of international business
management.

Dr. Axel Herberg is leaving Gerresheimer under his own volition
after his successful work as CEO. Dr. Herberg served the company for
twenty years, fifteen of them as a member of the Management Board and
ten as CEO. The Supervisory Board thanks him for his outstanding
achievements and successful collaboration over the past years. It
welcomes Dr. Axel Herberg as a new member of the Supervisory Board,
to which he was elected by the Annual General Meeting on April 29,
2010 by a large majority of votes.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of
high-quality specialty products made of glass and plastic for the
global pharma & healthcare industry. Our wide product spectrum ranges
from pharmaceutical vials to complex drug delivery systems, such as
syringe systems, insulin pens and inhalers, for safe dosage and
application. Together with our partners we develop solutions which
set standards and have role-model status throughout their respective
business sectors.

Our Group of companies achieves in Europe, North and South America
and Asia sales of about ?1 billion and employs around 9,400 people.
Through top-class technologies, convincing innovations and targeted
investments we are systematically expanding our strong market
position.

P.S.: If required, we can send you high-resolution data. Reprint
free of charge. Please send specimen copy to Gerresheimer. (c)
Gerresheimer AG

Originaltext: Gerresheimer AG
digital press kits: http://www.presseportal.de/pm/9072
press kits via RSS: http://www.presseportal.de/rss/pm_9072.rss2
ISIN: DE000A0LD6E6

Press Contact:
Jens Kürten
Director Corporate Communication & Marketing
Telephone +49 211 6181-250
Telefax +49 211 6181-241
E-Mail j.kuerten@gerresheimer.com

Investor Relations Contact
Anke Linnartz
Director Investor Relations
Telephone +49 211 6181-314
Telefax +49 211 6181-121
E-Mail a.linnartz@gerresheimer.com